Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

JUNE Medical Launches Galaxy II™ LUX and Partnership with Vivo Surgical

December 14, 2020

JUNE Medical has announced the launch of the Galaxy II™ LUX – the worlds’ first self-retaining ring retractor with light.

JUNE Medical notes the Galaxy II LUX combines the award-winning Galaxy II retractor with Vivo Surgical’s KLARO™ in vivo LED device, which can be mounted on the retractor via a purpose-designed clip.

This unique partnership provides surgeons with a revolutionary solution, giving them better access and a clearer view of the surgical site, and eliminating the disadvantages of using overhead lighting or personal head torches.

JUNE Medical notes the lightweight, self-retaining Galaxy II retractor features unique cam locks that allow single-handed adjustment on the frame, and there are multiple frames and hooks to suit a range of procedures. The KLARO lighting tip then offers the highest surgical light intensity on the market, with four settings to match the needs of different operations, while maintaining a safe operating temperature of below 38 °C. With a650 mm long cable, compact 4.6 mm diameter and flexible structure, the light can be effortlessly positioned during surgery to offer up to ~340° of illumination inside deep and narrow wounds.

The Galaxy II LUX is ideal for use in a variety of procedures, including ENT, colorectal, orthopedic, gynecological and other open surgeries. Angela Spang, CEO of JUNE Medical commented: “We are thrilled to be working with Vivo Surgical to offer this gamechanger. This kit helps to overcome a number of pain points, ensuring uniform site illumination from within an open surgical cavity, reducing the need for light repositioning and eliminating the risk of patient infection from contaminated light handles, as well as improving ergonomics for surgeons. We’re also excited about the opportunities this kit will bring for our charity work in countries where surgical lighting is sometimes a smartphone torch!”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy